The move aimed at helping boost production as demand currently outstrips supply.
“The agreement will see Novartis utilizing its aseptic manufacturing facilities at its site in Stein, Switzerland,” Novartis said in a statement on Friday. External link
“Subject to reaching a final agreement, Novartis plans to commence production in the second quarter of 2021.”
This is the first of multiple agreements “to leverage manufacturing capacity and capabilities to address pandemic, supporting global supply of Covid-19 vaccine” being explored by Novartis, the company said.
The Pfizer-BioNTech Covid-19 Vaccine has been authorised for use by the health regulatory authorities of about 50 countries, including Switzerland. It has also received authorisations for emergency use countries like the United Kingdom and the United States.
Switzerland will be affected by the temporary delay to the Pfizer-BioNTech Covid-19 vaccine in Europe, the Swiss health authorities have already confirmed.
Moderna has warned Switzerland that its Covid-19 vaccine deliveries would be delayed, the Swiss Federal Office of Public Health said on Thursday. This will lead to a shortfall in February that the Swiss expect the US company to make up in March, Reuters has reported.External link
First large-scale alpine solar plant approved in Switzerland
This content was published on
The approval was met with satisfaction by the project's organisers, but it also brings with it a certain amount of pressure.
Medieval squirrels may have ‘helped spread leprosy’
This content was published on
An examination of squirrel remains in the United Kingdom has opened up interesting questions and possibilities in terms of the history of the disease.
Swiss money laundering office registers record number of reports
This content was published on
The Money Laundering Reporting Office Switzerland (MROS) registered a record number of reports of suspicious activity last year.
Two teens accused of planning terror attack released from custody
This content was published on
The Schaffhausen judiciary has released the two teenagers from custody who allegedly planned bomb attacks in Switzerland.
This content was published on
Switzerland will be affected by the temporary delay to the Pfizer-BioNTech Covid-19 vaccine in Europe, the Swiss health authorities have confirmed.
You can find an overview of ongoing debates with our journalists here . Please join us!
If you want to start a conversation about a topic raised in this article or want to report factual errors, email us at english@swissinfo.ch.